IOVA
Iovance Biotherapeutics, Inc.
$9.87
Earnings Summary
Revenue | $31.11Mn |
Net Profits | $-97.1Mn |
Net Profit Margins | -312.16% |
Highlights
Iovance Biotherapeutics, Inc.’s revenue jumped 12969.75% since last year same period to $31.11Mn in the Q2 2024. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 4250.49% jump in its revenue since last 3-months.
Iovance Biotherapeutics, Inc.’s net profit jumped 8.85% since last year same period to $-97.1Mn in the Q2 2024. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 14.05% jump in its net profits since last 3-months.
Iovance Biotherapeutics, Inc.’s net profit margin jumped 99.3% since last year same period to -312.16% in the Q2 2024. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 98.02% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Iovance Biotherapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Year | -0.42 |
Highlights
Iovance Biotherapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.42.
Key Ratios
Key ratios of the Iovance Biotherapeutics, Inc. post its Q2 2024 earnings
Earning Per Share (EPS) | -0.34 |
Highlights
Iovance Biotherapeutics, Inc.’s earning per share (EPS) jumped 27.66% since last year same period to -0.34 in the Q2 2024. This indicates that the Iovance Biotherapeutics, Inc. has generated 27.66% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | -0.42 | -0.42 | 0% |
2024-08-08 | -0.35 | -0.34 | 2.86% |
₹0 US Stocks a/c Opening Fee